Announcing the 2026 Phelan-McDermid Syndrome Drug Development Symposium
This April, CureSHANK will convene the third annual Phelan-McDermid Syndrome Drug Development Symposium, a two-day, in-person event focused on accelerating therapeutic development for Phelan-McDermid syndrome (PMS).
At this year’s symposium, scientists, clinical investigators, industry leaders, and investors will come together to discuss the most critical scientific, clinical, and strategic questions facing PMS drug development today.
We invite members of the research community, biotechnology and pharmaceutical leaders, clinicians, investors, and advocates to join us for this important gathering.
Join us for a symposium that spans foundational knowledge of PMS, translational science discoveries, and the latest developments in biomarkers, outcome measures, and clinical trials. The event will culminate in a dynamic forum of drug developers and investors sharing real-world insights, challenges, and opportunities in neurodevelopmental disease therapeutic innovation.
Symposium Overview
On April 13th and 14th, 2026, CureSHANK will convene the third Phelan-McDermid Syndrome Drug Development Symposium, a two-day, in-person meeting focused on accelerating therapeutic drug development for PMS.
Be part of a focused, high-impact gathering dedicated to advancing treatments for PMS. Over two days at CURE in Midtown Manhattan, leading experts in preclinical and clinical research will explore the latest advances in translational science, clinical trial design, endpoint strategy, biomarker development, and more.
The symposium will bring together stakeholders across the ecosystem working to translate promising science into effective therapies for individuals living with PMS.
The event will conclude with a dynamic forum featuring drug developers and investors, offering real-world perspectives on the challenges and opportunities shaping the future of neurodevelopmental disease therapeutic innovation.
Event Details
Date: Monday, April 13 – Tuesday, April 14, 2026
Location: CURE | 345 Park Avenue South, New York, NY
Format: In-person symposium with scientific sessions, panels, poster presentations, and structured networking opportunities
Participation in this event is free of charge. Poster presenters selected to present may also be eligible for travel support.
Registration Deadline: April 3, 2026
Who Should Attend
This symposium is designed for stakeholders across the PMS therapeutic development ecosystem, including:
Academic researchers and scientists working on SHANK3 or PMS and related neurodevelopmental disorders
Biopharmaceutical and biotech teams advancing or exploring PMS-relevant programs
Clinical trialists, outcomes researchers, and biomarker experts
Investors and strategic partners interested in rare disease and neurodevelopmental therapeutics
Sponsorship Opportunities
The CureSHANK Symposium provides a unique opportunity to engage directly with leaders in translational science and therapeutic development for PMS. Organizations interested in supporting this important convening can explore symposium sponsorship opportunities.
For more information, please contact:
connect@cureshank.org